QGH
- Product code
- QGH
- Device name
- Electroconvulsive Therapy Device For Catatonia, Major Depressive Disorder, And Bipolar Disorder
- Device class
- Class 2
- 21 CFR
- 21 CFR 882.5940
- Medical specialty
- Neurology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 9
FDA classification definition
Catatonia or a severe major depressive episode (MDE) associated with major depressive disorder (MDD) or bipolar disorder (BPD) in patients age 13 years and older who are treatment-resistant or who require a rapid response due to the severity of their psychiatric or medical condition.
Official FDA classification page: QGH
Classification and pathway per current FDA publications. Data from openFDA (CC0).